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Tokyo, JapanObjectives This study sought to identify useful predictors for hemodynamic improvement and risk of
reperfusion pulmonary edema (RPE), a major complication of this procedure.
Background Percutaneous transluminal pulmonary angioplasty (PTPA) has been reported to be
effective for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH). PTPA has not
been widespread because RPE has not been well predicted.
Methods We included 140 consecutive procedures in 54 patients with CTEPH. The ﬂow appearance
of the target vessels was graded into 4 groups (Pulmonary Flow Grade), and we proposed PEPSI
(Pulmonary Edema Predictive Scoring Index) ¼ (sum total change of Pulmonary Flow Grade
scores)  (baseline pulmonary vascular resistance). Correlations between occurrence of RPE and
11 variables, including hemodynamic parameters, number of target vessels, and PEPSI, were analyzed.
Results Hemodynamic parameters signiﬁcantly improved after median observation period of 6.4
months, and the sum total changes in Pulmonary Flow Grade scores were signiﬁcantly correlated with
the improvement in hemodynamics. Multivariate analysis revealed that PEPSI was the strongest factor
correlated with the occurrence of RPE (p < 0.0001). Receiver-operating characteristic curve analysis
demonstrated PEPSI to be a useful marker of the risk of RPE (cutoff value 35.4, negative predictive
value 92.3%).
Conclusions Pulmonary Flow Grade score is useful in determining therapeutic efﬁcacy, and PEPSI is
highly supportive to reduce the risk of RPE after PTPA. Using these 2 indexes, PTPA could become
a safe and common therapeutic strategy for CTEPH. (J Am Coll Cardiol Intv 2013;6:725–36)ª 2013 by
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726Chronic thromboembolic pulmonary hypertension (CTEPH)
is a progressive disease in which chronic thromboembolism
in the pulmonary arteries leads to pulmonary hypertension
(1–9). Medical therapies using anticoagulation and pulmo-
nary vasodilators are somewhat effective for the treatment of
CTEPH (1,10,11), and the most powerful conventional
therapeutic strategy is invasive surgical pulmonary endarter-
ectomy (12–16). However, our group and others recently
reported that percutaneous transluminal pulmonary angio-
plasty (PTPA) markedly improved subjective symptoms and
pulmonary hemodynamics in patients with CTEPH
and may be a promising new therapeutic strategy (17–19).
Reperfusion pulmonary edema (RPE) is a major compli-
cation of PTPA. In addition, pulmonary endarterectomy,Abbreviations
and Acronyms
BNP = B-type natriuretic
peptide
CI = conﬁdence interval
CO = cardiac output
CTEPH = chronic
thromboembolic pulmonary
hypertension
PAP = pulmonary arterial
pressure
PAWP = pulmonary artery
wedge pressure
PEPSI = Pulmonary Edema
Predictive Scoring Index
PTPA = percutaneous
transluminal pulmonary
angioplasty
PVR = pulmonary vascular
resistance
RAP = right atrial pressure
ROC = receiver-operating
characteristic
RPE = reperfusion pulmonary
edemabut not PTPA, can remove the
majority of lesions in 1 procedure.
Each lesion dilated by PTPA is
still exposed to high pulmonary
arterial pressure (PAP), and this
could explain why the incidence
of reperfusion lung injury
following PTPA is higher than
that after pulmonary endarterec-
tomy. In 2001, Feinstein et al.
(20) showed that pulmonary
hemodynamics were markedly
improved by pulmonary angio-
plasty in 18 patients, and that 11
(61%) of the 18 patients devel-
oped RPE. In our previous
report, 27 (53%) of 51 cases of
overall procedures and 19 (68%)
of 28 cases of the ﬁrst procedures
developed RPE, and patients
with more severe clinical signs
and/or hemodynamic dysfunc-
tion at baseline had a higher risk
of RPE after PTPA (17).
This study, therefore, sought
to identify useful predictors for
the risk of RPE as well as hemodynamic improvement
after PTPA.
Methods
Study subjects. One hundred and forty consecutive PTPA
procedures (54 ﬁrst, 46 second, 20 third, 17 fourth, and
3 ﬁfth procedures) in 54 patients with CTEPH who
attended Keio University Hospital or Kyorin University
Hospital, Japan, from January 2009 to May 2012 were
enrolled. These 54 patients were diagnosed with CTEPH
by demonstration of organized pulmonary thromboembo-
lism using contrast-enhanced lung computed tomography,
perfusion lung scintigraphy, and pulmonary angiography,and ruling out collagen vascular disease, pulmonary disease,
left heart abnormality, and other systemic diseases by blood
tests, pulmonary function tests, and echocardiography.
Among the 54 enrolled patients, 8 patients had 1 procedure,
26 had 2, 3 had 3, 14 had 4, and 3 had 5 procedures. All the
patients provided informed consent, and the PTPA treat-
ment and study protocol was approved by the institutional
review boards of the hospitals.
Examinations. Patients underwent right-sided heart cathe-
terization just before PTPA, just after PTPA, and at the
follow-up examinations. The timing of the follow-up right-
sided heart catheterization after the last procedure was
essentially 1 to 3 months, 6 months, 12 months, and every 1
year thereafter. The right atrial pressure (RAP), PAP, and
pulmonary artery wedge pressure (PAWP) were measured at
right-sided heart catheterization. The cardiac output (CO)
was determined by the Fick technique using assumed oxygen
consumption. Cardiac index was calculated by dividing CO
by body surface area. The pulmonary vascular resistance
(PVR) was calculated by subtracting PAWP from mean
PAP and dividing by CO.
Six-min-walk distance and plasma B-type natriuretic
peptide (BNP) level were measured both before PTPA and
at follow-up with right-sided heart catheterization.
Indications for PTPA. The patients were selected as potential
candidates for PTPA based on the following criteria:
1) more than 30 mm Hg of mean PAP or more than 3.75
Wood units (300 dynes/s/cm5) of PVR; 2) greater than
New York Heart Association functional class II; 3) patient’s
own wish to undergo PTPA; and 4) did not fulﬁll after-
mentioned exclusion criteria.
Adult patients with CTEPH who could understand the
procedure of PTPA and possible complications and could
give informed consent of their own free will were selected.
Both the pulmonary endarterectomy and PTPA procedures
were explained to them, including the possible complica-
tions of PTPA (based on the previous report by Feinstein
et al. [20]) and the beneﬁts and risks of pulmonary endar-
terectomy, the latter given by an experienced surgeon in
some cases. Pulmonary endarterectomy was then recom-
mended based on the evidence in patients whose main
lesions were centrally located and whose operative risks were
typical of the procedure. Our study basically selected
patients with almost all the pulmonary thromboembolic
lesions existing in the lobar, segmental, and subsegmental
pulmonary arteries. PTPA targets basically the same lesions
(lobar, segmental, and subsegmental lesions) as pulmonary
endarterectomy, except for cases whose lesions exist in the
main trunks of the pulmonary arteries. Thus, our study
selected patients who rejected pulmonary endarterectomy or
for whom we suggested PTPA was more appropriate than
pulmonary endarterectomy because of their advanced age
or poor physical condition. Additionally, our study
included patients who had already undergone pulmonary
Table 1. Deﬁnitions of Perfusion in Pulmonary Flow Grade
Grade 0 (no perfusion or penetration with minimal perfusion of pulmonary arteries):
There is no antegrade ﬂow beyond the point of stenosis or occlusion in
pulmonary arteries, or the contrast material passes beyond the area of lesions, but
“hangs up” and fails to opacify the entire pulmonary artery bed distal to the
lesions for duration of the cine run. The no-reﬂow phenomenon, which means
persistent microcirculatory impairment after angioplasty, is included in this grade.
Grade 1 (partial perfusion of pulmonary arteries): The contrast material passes across
the lesions and opaciﬁes the pulmonary artery bed distal to the lesions. However,
the rate of entry of contrast material into the vessels distal to the lesions or its rate
of clearance from the distal bed of pulmonary artery (or both) are perceptibly
slower than its entry into or clearance from comparable areas not perfused by the
previously stenosed or occluded vessel.
Grade 2 (complete perfusion of pulmonary arteries and partial perfusion of
pulmonary veins): Antegrade ﬂow into the bed of pulmonary artery distal to the
lesions occurs as promptly as antegrade ﬂow into the bed proximal to the lesions.
However, the rate of appearance of contrast material from the bed of pulmonary
veins perfused by the previously stenosed or occluded pulmonary artery or the
rate of contrast clearance from the bed of perfused pulmonary veins (or both) is
perceptibly slower than that from comparable areas not perfused by the
previously stenosed or occluded vessel.
Grade 3 (complete perfusion of both pulmonary arteries and veins): Antegrade ﬂow
into the bed of the pulmonary artery distal to the lesions occurs as promptly as
antegrade ﬂow into the bed proximal to the lesions. Plus, the rate of appearance
of contrast material from the bed of pulmonary veins perfused by the previously
stenosed or occluded pulmonary artery and the rate of contrast clearance from
the bed of perfused pulmonary veins are as promptly as those from comparable
areas not perfused by the previously stenosed or occluded vessel.
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727endarterectomy but had residual pulmonary hypertension
due to lesions that could not be removed with pulmonary
endarterectomy.
Meanwhile, our exclusion criteria were patients who were
unable to lie on the treatment table during the procedure
because of mental disorders, those with active infectious
disease, and those who had serious complications such as
hepatic disease, kidney disease, hemorrhagic tendency, or
poorly controlled diabetes mellitus or hypertension.
During our study (from January 2009 to May 2012),
1 patient had pulmonary endarterectomy because the main
lesions were centrally located, and another potential candi-
date of PTPA, other than the 54 enrolled patients in this
study, selected pulmonary endarterectomy after explanation
of both pulmonary endarterectomy and PTPA, including
their possible complications and beneﬁts.
Procedure of PTPA. Warfarin was stopped for 3 days before
the procedure and replaced by heparin. The goal of acti-
vated clotting time during the procedure was 250 to 300 s.
Warfarin was restarted after the procedure, and heparin
infusion was continued until the efﬁcacy of warfarin
reached the optimal range. All patients were treated with
warfarin long term. A catheter was inserted via the femoral
vein or right jugular vein, with the latter selected if the
patient had a ﬁlter in the inferior vena cava. A balloon
wedge pressure catheter was inserted into the main pul-
monary artery tract and replaced by a long spring guidewire
before a 7- to 9-F long sheath was inserted into the main
pulmonary artery tract. A 6- to 8-F guide catheter was then
inserted through the long sheath, and a 0.014-inch
guidewire was inserted through the target lesion. The target
lesions were dilated by a 1.5- to 9.0-mm monorail or over-
the-wire balloon catheter. The balloons were inﬂated by
hand through inﬂation device for 15 to 30 s until they were
fully expanded.
Angiography of the targeted side of the lung was per-
formed before each procedure to select and determine the
target lesions, but was not performed after the procedure.
To determine the ﬂow appearance and ﬂow grade after
angioplasty, selective angiography of the treated vessels was
performed through catheters engaged in the treated vessels.
The balloon size was determined by measurement of vessel
diameter by intravascular ultrasound or the ruler to
measure the vessel diameter on cine freeze-frame. The
procedural success for each target lesion was deﬁned by
dilation of the lesion diameter to the same size as the
reference vessel’s diameter or by the perfusion ﬂow level of
Pulmonary Flow Grade 3 (shown in Table 1) after balloon
dilation.
The enrolled patients had been treated with an appro-
priate combination of oral vasodilators such as bosentan,
ambrisentan, sildenaﬁl, tadalaﬁl, or beraprost before the
procedure. Epoprostenol, treprostinil, and iloprost were not
used in any of the patients.Selection of target vessels. The selection criteria of target
vessels are as follows: 1) the lobe with the poorest perfusion
is identiﬁed by lung perfusion scintigraphy; 2) if any of the
lobes in both lungs have the same degree of poor pulmonary
blood ﬂow in lung perfusion scintigraphy, the lobes in the
right lung are selected because the manipulation technique
in the right lung is relatively easier than that in the left lung,
and the total blood ﬂow distribution of the right lung is
physiologically larger than that of the left lung; 3) if any of
the lobes, including the inferior lobe in either the right or the
left lung, have the same degree of poor distribution of
pulmonary blood ﬂow in lung perfusion scintigraphy, the
inferior lobe is selected because it has physiologically more
distribution of blood ﬂow compared with the superior lobe
and middle lobe; and 4) the targeted segmental branches are
selected based on pulmonary angiography, which means,
essentially, the lesions with less anatomical information
about peripheral branches, such as chronic total occlusion
and pouch defects, should be put off, and the lesions with
more information about peripheral branches, such as webs
and bands and abrupt narrowing, are selected, because
information about peripheral branches distal to the target
lesions are important in order to safely perform the
procedure.
These criteria are particularly important in the ﬁrst-time
procedure. The purposes of these criteria are: 1) to perform
a safe procedure without exacerbation of hemodynamics, in
particular, in cases with poorer pulmonary hemodynamics;
2) to improve pulmonary hemodynamics as effectively as
possible; and 3) to achieve successful revascularization
Figure 1. Representative Angiogram of PTPA
(A) Angiogram before percutaneous transluminal pulmonary angioplasty (PTPA). The target bifurcation lesion is indicated by an arrow. (B) Dilation of 1 of the branch
lesions by balloon catheter. (C) Dilation of another branch lesion by balloon catheter. (D) Angiogram after PTPA.
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728without complications. But, to achieve ﬁnal obliteration of
pulmonary hypertension, almost all of the remaining lesions
need to be treated. Thus, the remaining lesions are selected
in series in accordance with the aforementioned criteria at
the second session of PTPA.
Analysis of hemodynamic improvement at follow-up. The
hemodynamic parameters at baseline, just before the ﬁrst
procedure, and at the time of follow-up after the last
procedure were compared. Although the number of en-
rolled patients was 54, follow-up analysis was performed
in 44 patients, in whom the follow-up examinations had
been performed for a total observation period of more than
50 days.
Classiﬁcation of pulmonary ﬂow appearance. Table 1 shows
the classiﬁcation of pulmonary ﬂow appearances seen with
selective segmental pulmonary angiography. We named the
classiﬁcation “Pulmonary Flow Grade.” The deﬁnitions of
perfusion in Pulmonary Flow Grade were described by
reference to the previous report regarding Thrombolysis inMyocardial Infarction classiﬁcation in myocardial infarction
(21). The ﬂow appearance of the target vessels just before
and after angioplasty was graded. The correlations between
the change in ﬂow grade and hemodynamic changes were
investigated.
The change of Pulmonary Flow Grade score at the time
of the procedure was calculated based on the levels of
segmental branches of target pulmonary arteries. To cite
a case in which a segmental branch (for example, A8) had 2
subsegmental branches (for example, A8a and A8b) and
only 1 subsegmental branch (A8a or A8b) with baseline
Pulmonary Flow Grade 1 was treated to grade 2, the change
in score of Pulmonary Flow Grade was calculated as 0.5
(because the difference of grade 1 to grade 2 is divided by 2,
the number of subsegmental branches). To cite another case
in which a segmental branch (for example, A10) with
baseline Pulmonary Flow Grade 1 was treated to grade 3,
the change in score of Pulmonary Flow Grade was calcu-
lated as 2.
Table 2. Baseline Characteristics of Patients
Enrolled Patients (N ¼ 54)
Age, yrs 63.5 (54.8 to 70.2)
Sex, female/male 41/13
NYHA functional class, I/II/III/IV 0/4/40/10
Number of patients previously treated with
pulmonary endarterectomy
6
Mean RAP, mm Hg 5 (3 to 7)
Mean PAP, mm Hg 42.5 (37.0 to 52.3)
PVR, Wood units 9.2 (6.9 to 15.0)
Cardiac index, l/min/m2 2.5 (1.8 to 2.9)
PAWP, mm Hg 7 (5 to 10)
SvO2, % 66.0 (59.7 to 72.4)
6-min-walk distance, m 360 (278 to 407)*
BNP, pg/ml 126 (54 to 390)
Values are n or median (25th to 75th percentile). *n ¼ 50, because 4 patients did not undergo
the 6-min-walk examination due to a gait disorder or dyspnea.
BNP ¼ B-type natriuretic peptide; NYHA ¼ New York Heart Association; PAP ¼ pulmonary
arterial pressure; PAWP ¼ pulmonary artery wedge pressure; PVR ¼ pulmonary vascular
resistance; RAP ¼ right atrial pressure; SvO2 ¼ mixed venous oxygen saturation.
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729Measurement of the ratio of pressures across the
lesions. The pressure difference across the stenosis in the
target vessel was measured by a pressure wire (PrimeWire
PRESTIGE, Volcano, San Diego, California), as the ratio
of distal to proximal pressures across the target lesion. The
correlation between Pulmonary Flow Grade score and the
ratio of proximal to distal pressures of the target lesions was
analyzed.
Deﬁnition of Pulmonary Edema Predictive Scoring Index. We
proposed a new index, the Pulmonary Edema Predictive
Scoring Index (PEPSI), to reﬂect both the change in
angiographic ﬂow and the baseline severity of pulmonary
hypertension due to CTEPH. Thus, PEPSI is deﬁned as
follows:
PEPSI ¼ sum total change of Pulmonary Flow Grade
scores in PTPA
 baseline PVRðWood unitsÞ:
Predictive variables for RPE. Eleven variables were chosen to
analyze the relation to RPE. The predictive variables com-
prised hemoglobin, estimated glomerular ﬁltration rate,
BNP, whether the procedure was the ﬁrst session or not,
mean RAP, mean PAP, cardiac index, PVR, number of
target vessels, and PEPSI.
Statistical analysis. All data are presented as median (25th to
75th percentiles). Signiﬁcant differences were determined
using the Mann-Whitney test or Wilcoxon matched pairs
signed rank test, as appropriate. Correlation between the sum
total change of Pulmonary Flow Grade scores and changes in
the hemodynamic parameters from baseline to follow-up
were analyzed using the Spearman rank correlation coefﬁ-
cient. Correlation between pulmonary ﬂow grade and the
ratio of pressure difference was analyzed using the Spearman
rank correlation coefﬁcient. Univariate analysis based on the
logistic regression analysis was used to examine the rela-
tionship between the occurrence of RPE and the predictive
variables. The results were expressed as odds ratios with 95%
conﬁdence intervals (CI). Multivariate analysis based on
logistic regression analysis was used to examine the inde-
pendent effect of each variable on the occurrence of RPE.
The best predictive threshold for RPE was sought by means
of receiver-operating characteristic (ROC) curves. The
Youden index was utilized to deﬁne the best cutoff value on
the ROC curve. Adjustments for the nonindependence of
multiple procedures within patients were not made. A value
of p < 0.05 was considered statistically signiﬁcant.Results
Clinical improvement by PTPA. A representative pulmonary
angiogram during the PTPA is shown in Figure 1. The
baseline characteristics of the 54 enrolled patients are
detailed in Table 2. Among the 44 patients enrolled forfollow-up analysis, the median observation period from the
ﬁrst procedure to the last follow-up conducted on each
patient was 6.4 (4.5 to 8.6) months. A comparison of the
examinations at baseline with those at follow-up is presented
in Figure 2. Right-sided heart catheterization demonstrated
a signiﬁcant improvement in hemodynamic parameters
(mean RAP, 5.5 [3 to 7] vs. 3.0 [2 to 5.8] mm Hg; mean
PAP, 43 [38 to 53] vs. 25 [21 to 29] mm Hg; PVR, 9.4 [7.2
to 14.8] vs. 3.8 [2.9 to 5.5] Wood units; and cardiac index,
2.5 [1.9 to 2.9] vs. 2.8 [2.3 to 3.7] l/min/m2; baseline vs.
follow-up, respectively; p < 0.01). The right ventricular
systolic pressure was also signiﬁcantly improved from 84
(74 to 99) mm Hg to 48 (42 to 56) mm Hg (p < 0.01).
Plasma BNP was signiﬁcantly decreased after PTPA (126
[61 to 390] vs. 33 [20 to 54] pg/ml; p < 0.01). Although
some of the data for the 6-min-walk distance were missing
due to refusal of examination by some patients because of
gait disorders or dyspnea, the 6-min-walk distance was
signiﬁcantly lengthened at follow-up from 342 (243 to 396)m
to 405 (348 to 495) m (p < 0.01, n ¼ 33).
Correlations between total change in Pulmonary Flow Grade
scores and hemodynamic changes. Among the 140 proce-
dures in the 54 enrolled patients, the total number of target
vessels was 525, the average number of target vessels per
procedure was 4.0 (2.3 to 5.0), the average number of
procedures per patient was 2 (2 to 4), and the average
number of target vessels per patient was 9.5 (6.3 to 13.0).
The duration of each procedure was determined by the
extent of x-ray exposure, ﬂuoroscopy times, and amount of
contrast material in regard to the patients’ renal function and
cardiac function. Thus, the reason why most patients
underwent multiple procedures is because if all target lesions
were treated at 1 procedure, those parameters would be over
Figure 2. Therapeutic Efﬁcacy of PTPA
Hemodynamic changes in mean right atrial pressure (RAP) (A), mean pulmonary arterial pressure (PAP) (B), pulmonary vascular resistance (PVR) (C), cardiac index (CI)
(D), plasma B-type natriuretic peptide (BNP) (E), and 6-min-walk distance (6MWD) (F) at follow-up after percutaneous transluminal pulmonary angioplasty (PTPA). All
hemodynamic parameters, BNP, and 6-min walk distance were signiﬁcantly improved at follow-up. *p < 0.01 versus baseline.
Table 3. Distribution of Pulmonary Flow Grade Score of Target
Vessels in PTPA
Pulmonary Flow Grade
Score
Target Vessels Before
Angioplasty
Target Vessels After
Angioplasty
0 187 (35.6) 26 (5.0)
1 275 (52.4) 33 (6.3)
2 62 (11.8) 100 (19.0)
3 1 (0.2) 366 (69.7)
Values are n (%).
PTPA ¼ percutaneous transluminal pulmonary angioplasty.
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730the limit. The average x-ray exposure, ﬂuoroscopy times, and
amount of contrast material per procedure were 1,531 (765
to 2,621) mGy, 74.1 (57.9 to 89.9) min, and 325 (250 to
370) ml, respectively.
The changes in Pulmonary Flow Grade scores from
baseline to just after the procedure are shown in Table 3;
approximately 88% of target vessels belonged to Pulmonary
Flow Grade score 0 or 1 before the procedures, but ap-
proximately 89% of the target vessels changed to Pulmonary
Flow Grade score 2 or 3 after angioplasty.
Correlations between the sum total changes in Pulmonary
Flow Grade scores and the change in hemodynamic
parameters such as PVR and mean PAP at follow-up were
analyzed (Fig. 3). The sum total change of Pulmonary Flow
Grade scores at the time of the procedure was signiﬁcantly
correlated with the change in PVR and mean PAP at
follow-up (p < 0.05). However, the total number of target
vessels at the time of the procedure was not correlated with
the change of PVR nor mean PAP (data not shown).
Correlations between Pulmonary Flow Grade scores and the
ratio of pressures across the lesions. For all the lesions with
Pulmonary Flow Grade 0, it was not possible to mea-
sure pressure differences by a pressure wire. Thirty-one
measurements of the ratio of the proximal to the distalpressures of the target lesions were performed in a total of
15 target vessels with Pulmonary Flow Grade 1 to 3 in 6
patients. Figure 4 shows the correlation between the
Pulmonary Flow Grade score and the pressure ratios,
demonstrating a strong correlation (p < 0.0001).
Complications other than RPE. Among the 54 enrolled
patients, 1 patient with baseline severe right heart failure
developed pulmonary hemorrhage as a complication because
of perforation by the wire. The perforation was completely
sealed, but right heart failure was exacerbated, and the
patient died 2 days after the procedure. Therefore, the
mortality associated with PTPA was 1.9% in this study.
Figure 3. Correlations Between Sum Total Change of Pulmonary Flow
Grade Scores and Changes in Hemodynamic Parameters After the Follow-
Up Period
The sum total change of Pulmonary Flow Grade scores (based on Table 1) was
signiﬁcantly correlated with changes in PVR (A) and mean PAP (B) (respec-
tively, p ¼ 0.01, Rs ¼ 0.3636 in PVR, Rs ¼ 0.3495 in mean PAP). Changing ratio
of PVR ¼ (baseline PVR  follow-up PVR)/baseline PVR; changing ratio of
mean PAP ¼ (baseline mean PAP  follow-up mean PAP)/baseline mean PAP.
Abbreviations as in Figure 2.
Figure 4. Correlation Between Pulmonary Flow Grade Score and the Ratio
of Proximal and Distal Pressures of the Target Lesions
Pulmonary Flow Grade score was strongly correlated with the pressure ratios
(p < 0.0001, Rs ¼ 0.9643).
Table 4. Classiﬁcation and Frequency of RPE
Grade Deﬁnition of Graded RPE
Number of
Procedures
1 No signiﬁcant recognition of reperfusion pulmonary
edema on chest x-ray
87 (62)
2 Mild or small reperfusion pulmonary edema on chest
x-ray, but automatic improvement with only
a small increase in oxygen for a few days
35 (25)
3 Moderate reperfusion pulmonary edema on chest
x-ray that needed elevated concentration of
oxygen administered via oxygen mask to maintain
arterial saturation at optimum level
9 (6)
4 Moderate to severe reperfusion pulmonary edema
on chest x-ray needing non-invasive positive
pressure ventilation with high-concentration
oxygen inhalation
7 (5)
5 Extremely severe reperfusion pulmonary edema on
chest x-ray needing artiﬁcial ventilation
2 (1)
Values are n (%).
RPE ¼ reperfusion pulmonary edema.
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731Among the total of 140 procedures, a dissection occurred in
1 of the targeted pulmonary arteries just after balloon dila-
tion in 2 procedures. The dissections did not expand, and
the hemodynamics did not change. Thus, the dissections
were left untouched. Extravascular leaks occurred just afterballoon dilation in another 4 procedures in which the
extravascular leak was stopped by prolonged low-pressure
dilation of the balloon in 1 procedure and by insertion of
a covered stent in the other cases. Consequently, there were
5 perforations, consisting of 1 case in the deceased patient
and 4 cases of extravascular leaks, and 2 dissections in this
study, which means that the rate of angiographic compli-
cations was 5% (7 of 140 procedures).
Classiﬁcation and frequency of RPE. Table 4 lists the deﬁ-
nitions of the classiﬁcation into 5 groups according to the
severity of RPE. Figure 5 shows representative chest x-ray
and chest computed tomographic images of RPE classiﬁed
into 5 groups based on the deﬁnitions in Table 4.
Figure 5. Representative Chest X-Ray and Chest CT Images of RPE
Reperfusion pulmonary edema (RPE) was classiﬁed as 5 levels based on the deﬁnitions in Table 4. CT ¼ computed tomographic; PTPA ¼ percutaneous transluminal
pulmonary angioplasty.
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732Eighty-seven procedures (62%) belonged to grade 1,
deﬁned as no signiﬁcant ﬁndings of pulmonary edema on
chest x-ray, and the other 53 procedures (38%) belonged
to grade 2 to 5, which indicated the occurrence of RPE.
Nine procedures (6.4%) were grade 4 or higher, which
indicates the occurrence of severe RPE, and these cases
needed noninvasive positive pressure ventilation or artiﬁ-
cial respiration. In 1 of the 2 procedures of grade 5, arti-
ﬁcial ventilation with a percutaneous cardiopulmonary
support (in other words, cardiopulmonary assist device or
venoarterial extracorporeal membrane oxygenation) was
needed for 5 days.
Comparison between procedures with and without RPE.
Table 5 shows a detailed comparison between the proce-
dures with and without RPE of grade 2 or higher. Among
the 53 procedures with RPE of grade 2 or higher, 31
procedures (58.5%) were the ﬁrst-session procedures of
each patient. This demonstrates that RPE occurred readily
at ﬁrst-time procedures. Furthermore, mean PAP, PVR,
cardiac index, and BNP were more markedly abnormal in
the procedures with RPE than in those without.Signiﬁcant predictive variables for RPE. We analyzed factors
associated with the occurrence of RPE of grade 2 or higher
(Table 6). Among the 11 variables, 8 variables (except for the
number of target vessels, hemoglobin level, and mean RAP)
at baseline were signiﬁcantly related to the occurrence of
RPE according to univariate analysis. Multivariate analysis
using variables with a signiﬁcant correlation of p < 0.001 in
univariate analysis demonstrated that PEPSI was most
strongly related to the occurrence of RPE (p < 0.0001).
ROC curve analysis for prediction of RPE. According to the
results of the multivariate analysis shown in Table 6, we then
analyzed the correlation between PEPSI and the occurrence
of RPE of grade 2 or higher. Figure 6A shows the distri-
bution of PEPSI with and without RPE of grade 2 or
higher. Figure 6B shows ROC curve analysis, which de-
monstrated an observed area under the curve of 0.87, cutoff
value of 35.4, sensitivity of 88.7% (95% CI: 77 to 96),
speciﬁcity of 82.8% (95% CI: 73 to 90), positive predictive
value of 75.8% (95% CI: 63 to 86), negative predictive value
of 92.3% (95% CI: 84 to 97), odds ratio of 37.6 (95% CI:
13.6 to 103.8), likelihood ratio of a positive test of 5.1
Table 5. Comparison of Variables Between Procedures With RPE
and Those Without It
Procedures With RPE
of Grade 2 or Higher
(n ¼ 53)
Procedures
Without RPE
(n ¼ 87) p Value
First session 31 (58.5) 23 (26.4) 0.0003*
Mean RAP, mm Hg 4 (3 to 7) 4 (2 to 6) 0.2022
Mean PAP, mm Hg 42 (38 to 50) 33 (28 to 41) <0.0001*
Cardiac index,
l/min/m2
2.5 (1.9 to 2.7) 2.6 (2.4 to 3.3) 0.0060*
PVR, Wood units 9.2 (7.0 to 14.6) 6.1 (3.9 to 8.7) <0.0001*
Number of target
vessels
4 (3 to 5) 3 (2 to 5) 0.1128
Sum total change of
Pulmonary Flow
Grade scores
6.0 (5.0 to 8.5) 4.0 (3.0 to 6.3) <0.0001*
PEPSI 54.6 (41.9 to 81.5) 24.5 (17.7 to 33.2) <0.0001*
Hemoglobin, g/dl 12.3 (11.3 to 13.5) 12.2 (10.6 to 13.6) 0.3353
eGFR, ml/min/1.73 m2 63.4 (52.0 to 80.0) 74.4 (62.6 to 90.3) 0.0186*
BNP, pg/ml 125 (48 to 365) 42 (22 to 70) <0.0001*
Values are n (%) or median (25th to 75th percentiles). PEPSI (Pulmonary Edema Predictive
Scoring Index) ¼ (sum total change of Pulmonary Flow Grade scores in percutaneous trans-
luminal pulmonary angioplasty)  baseline PVR (Wood units). First session, number of proce-
dures performed as ﬁrst session. *p < 0.05.
EGFR ¼ estimated glomerular ﬁltration rate; RPE ¼ reperfusion pulmonary edema; other
abbreviations as in Table 2.
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733(95% CI: 2.9 to 9.6), and likelihood ratio of a negative test of
0.14 (95% CI: 0.04 to 0.32).
Discussion
We proposed Pulmonary Flow Grade scores for the classi-
ﬁcation of the angiographic ﬂow appearances of target vessels
in PTPA, and PEPSI as a marker connecting the Pulmonary
Flow Grade scores with the baseline hemodynamic severity
of CTEPH. This study demonstrates that the sum totalTable 6. Statistical Analysis of Variables Correlated With the Occurrence of RPE
Univariate An
Odds Ratio 95% C
First session 3.920 1.918–8.
Mean RAP 1.093 0.970–1.
Mean PAP 1.075 1.038–1.
Cardiac index 0.417 0.225–0.
PVR 1.220 1.120–1.
Number of target vessels 1.123 0.925–1.
Sum total change of Pulmonary Flow Grade scores 1.284 1.124–1.
PEPSI 1.074 1.048–1.
Hemoglobin 1.138 0.938–1.
eGFR 0.977 0.958–0.
BNP 1.005 1.002–1.
Multivariate analysis was made using variables with signiﬁcant correlation of p < 0.001 in univariate a
CI ¼ conﬁdence intervals; other abbreviations as in Tables 2 and 5.change in Pulmonary Flow Grade scores is a good marker for
predicting hemodynamic improvement at follow-up, and
that PEPSI is useful to predict the risk of RPE in PTPA.
The present study found signiﬁcant improvement in
hemodynamic parameters, exercise capacity as indicated by
6-min-walk distance, and plasma BNP level after PTPA. In
combination with some previous studies (17–20), these
ﬁndings demonstrate that PTPA is clinically effective for
the treatment of CTEPH. Some previous reports have
demonstrated that about 45% to 55% of mean PAP and
65% to 70% of PVR decrease by pulmonary endarterectomy
(22–24). Furthermore, the outcomes of patients treated
medically have been reported sporadically (25–35), sug-
gesting that the clinical efﬁcacy of medical treatment tends
to be lower than that of invasive surgical treatment.
Meanwhile, in the results of our study, 42% of the mean
PAP and 60% of the PVR decreased at about 6 months after
PTPA. These ﬁndings suggest that the hemodynamic
outcomes by PTPA are improved, but are not superior to,
the outcomes by pulmonary endarterectomy. A large
multicenter collaborative study is required in the future to
compare the therapeutic efﬁcacy, mortality, and complica-
tions of PTPA with those of pulmonary endarterectomy
performed in experienced centers.
We proposed Pulmonary Flow Grade scores, which
classify selective pulmonary angiography ﬂow grade based on
the ﬂow appearance of the pulmonary veins perfused by the
targeted pulmonary arteries. In the present study, the sum
total change in Pulmonary Flow Grade scores was signiﬁ-
cantly correlated with hemodynamic changes of PVR and
mean PAP at follow-up. In particular, our previous report
demonstrated that the beneﬁts of PTPA cannot be esti-
mated by any immediate hemodynamic changes at the time
of the procedure (17), suggesting that the performance
guided by Pulmonary Flow Grade could more easily predictalysis Multivariate Analysis
I p Value Odds Ratio 95% CI p Value
215 0.0002* 1.958 0.692–5.578 0.2037
242 0.1423 d d d
116 <0.0001* 1.117 1.027–1.224 0.0088*
723 0.0013* d d d
344 <0.0001* 0.571 0.367–0.834 0.0029*
372 0.239 d d d
487 0.0002* 0.642 0.364–1.056 0.0827
106 <0.0001* 1.162 1.078–1.274 <0.0001*
390 0.1899 d d d
995 0.0143* d d d
008 <0.0001* 1.002 0.998–1.008 0.2479
nalysis. *p < 0.05.
Figure 6. Correlation Between PEPSI and the Occurrence of RPE
(A) Distribution of PEPSI (Pulmonary Edema Predictive Scoring Index) in the
presence [RPE (þ)] and absence of reperfusion pulmonary edema [RPE ()]. (B)
Receiver-operating characteristic curve analysis of PEPSI for prediction of RPE.
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734the therapeutic efﬁcacy at follow-up. Furthermore, in our
results, Pulmonary Flow Grade score was strongly correlated
with the ratio of the proximal to the distal pressures of the
target lesions obtained by a pressure wire, suggesting that
the practical utility of Pulmonary Flow Grade scores is
substantiated by these pressure ratios, which is an objective
method of measurement of stenosis.
RPE remains the most important complication of PTPA.
Indeed, Feinstein et al. (20) experienced RPE in 11 of 18
enrolled patients (61%). In this study, RPE was graded into
5 groups according to severity. As shown in Figure 5, the
RPE was recognized even in the opposite lung without
angioplasty, in particular in grade 3 or higher. Theseﬁndings raise the possibility that the occurrence of RPE is
mediated, not only by the direct injury or direct exposure of
high pressure in pulmonary arteries, but also by the indirect
spreading effect of inﬂammation via cytokines. A more
detailed exploration of mechanisms of RPE is desirable.
Among the 140 total procedures in this study, 53 procedures
(38%) were classiﬁed as grade 2 to 5, which indicates clear
occurrence of RPE, and all 9 cases with RPE of grade 4 or
higher, which indicates severe RPE, needed noninvasive
positive-pressure ventilation or artiﬁcial respiration. There-
fore, it would be highly risky to increase the sum total
change of Pulmonary Flow Grade scores blindly without
concern for the occurrence of RPE.
Comparison between the procedures with and without
RPE of grade 2 or higher demonstrated that the sum total
change in Pulmonary Flow Grade scores in cases with RPE
was signiﬁcantly higher than that in those without, and that
procedures in cases with greater clinical severity at baseline
had a higher risk of RPE. These ﬁndings conﬁrm that
PTPA should be performed based on the index reﬂecting
both angiographic ﬂow change and baseline severity of
pulmonary hypertension so as to obtain maximum thera-
peutic efﬁcacy and minimal risk of RPE at the same time.
The PEPSI, which is calculated by multiplying the sum total
change in Pulmonary Flow Grade scores by baseline PVR,
could therefore provide a new and useful index in clinical
settings. In this study, PEPSI was the strongest factor
related to the occurrence of RPE by multivariate analysis,
and ROC curve analysis demonstrated that the negative
predictive value of the PEPSI for the occurrence of RPE was
92.3% when the cutoff value was 35.4, suggesting the
possibility that PEPSI is a useful predictor of RPE.
These ﬁndings presuppose the usefulness of PTPA per-
formed based on PEPSI. To cite a case with baseline PVR of
12 Wood units, the targeted value of sum total change in
Pulmonary Flow Grade scores is 2.95, because the optimal
cutoff value of PEPSI, 35.4, divided by a PVR of 12 Wood
units equals 2.95. Thus, in such a case, if the Pulmonary
Flow Grade score is changed from 0 to 2 after angioplasty of
the ﬁrst target vessel, the procedure should be stopped
without angioplasty of the second target vessel because it
would be difﬁcult to maintain the change in Pulmonary Flow
Grade score within 0.95 (i.e., 2.95  2). Alternatively, the
procedure should be carefully continued so as to control the
change in Pulmonary Flow Grade score of the second target
vessel within 1 (for example, change in Pulmonary Flow
Grade score from 0 to 1, 1 to 2, or 2 to 3). To cite another
case with a baseline PVR of 5.0 Wood units, the targeted
value of the sum total change in Pulmonary Flow Grade
scores is 7.1 (i.e., 35.4/5.0). In such a case, if the Pulmonary
Flow Grade score is changed from 0 to 3 after angioplasty of
the ﬁrst target vessel and is changed from 0 to 2 after
angioplasty of the second target vessel, the change in
Pulmonary Flow Grade score of the third target vessel should
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735be controlled within 2 (for example, change in Pulmonary
Flow Grade score from 0 to 2 or 1 to 3). Additionally,
because PEPSI is calculated using the baseline PVR, in the
patients with lower PVR at baseline, it appears that it is
possible to treat more target lesions or reach more changes of
Pulmonary Flow Grade scores within 1 procedure, leading to
more beneﬁts in reduction in PVR and mean PAP.
Study limitations. The average observation period was not
very long, and the number of patients was relatively small.
Therefore, a study based on a longer observation period
following a greater number of patients is needed to conﬁrm
our results. Furthermore, a prospective study should be
performed to further demonstrate the predictive value of the
PEPSI. This is also a nonrandomized study with no control
arm, and these data are subject to selection bias.
Conclusions
PTPA is effective for the treatment of CTEPH, and the
sum total change in Pulmonary Flow Grade scores is very
useful for predicting the therapeutic efﬁcacy at follow-up.
With RPE recognized as the most important complication
of PTPA, PEPSI, which reﬂects both angiographic ﬂow
change and the baseline severity of pulmonary hypertension
due to CTEPH, could be a useful predictor of RPE. Our
ﬁndings lead to the following hypothesis: if PTPA is per-
formed guided by PEPSI, the risk of RPE will be minimized
and therapeutic efﬁcacy maximized, making PTPA a safe
and common therapeutic strategy for CTEPH. However,
the usefulness of PEPSI in this study is just a retrospective
ﬁnding and would need to be tested prospectively to see
whether clinical outcome is improved by using the PEPSI as
a guide for PTPA.
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